Trial Management STREAM

31. Illuminating IHC: From Biomarker To Clinical Trial Assay 5/2/2025

    Through this presentation, Immunohistochemistry (IHC) expert equip you with the knowledge needed to effectively utilize IHC in your research and clinical practice.

32. Secrets To A Collaborative Model To Improve TMF Management 10/30/2023

    Speakers from Phlexglobal and Regeneron share the benefits of their highly effective partnering model and lessons learned that you can apply in your organization.

33. Accelerating Clinical Trials Through Streamlined Confidential Disclosure Agreements 2/9/2026

    In this presentation, Dr. Christine Senn addresses the persistent challenge of study startup delays by focusing on a primary legal hurdle: the Confidential Disclosure Agreement (CDA).

34. Why Specialty Lab Samples Are So Vulnerable To Trial Execution Errors 7/17/2026

    Biomarkers and other specialty lab samples are among the most fragile parts of clinical trial execution, but what makes them so vulnerable to mishandling, and what are the effects?

35. Are Resource Constraints Impacting Your TMF Health? 8/22/2023

    Looking to quickly expand internal TMF resources with our anytime, anywhere TMF expertise? Unlock the potential to seamlessly access specialized TMF knowledge and support by viewing this presentation.

36. Why Disclosure Assessments Are The First Step To Improvement 1/8/2019

    Whether your organization lacks formal disclosure policies and procedures, or has longstanding SOPs in place, the best way to gauge the effectiveness of your clinical trial disclosure process is via a third-party assessment.

37. Build Your Diversity Action Plan With AI And Patient Insights 5/29/2024

    Discover how AI and patient insights can help you build a compliant Diversity Action Plan and overcome barriers to achieve diverse clinical trial enrollment.

38. Say It With Technology: How Alnylam Fosters A Connected Relationship With Sites 3/12/2021

    Alnylam Pharmaceuticals is developing an entirely new class of medicines and delivered the world’s first and only approved RNAi therapeutics in 2018 and 2019. Learn how Alnylam earned its reputation among investigators as a sponsor of choice by standardizing studies on a collaborative portal more than 6 years ago and leveraging technology to deliver results.

39. Ensuring Compliance In Gene Therapy Trials: IRB And IBC Views 9/23/2025

    Explore ethical and regulatory challenges in neurological gene therapy trials, with expert insights on IRB/IBC collaboration, consent protocols, and oversight for vulnerable populations.

40. TMF Management In Clinical Trials 3/13/2023

    Elevate your knowledge of clinical trials and the Trial Master File by exploring three critical topics.